Fortress Biotech stockholders elect seven directors, approve charter amendment at 2025 annual meeting

Fortress Biotech, Inc.

All seven director nominees elected: Rosenwald, Harvey, Hoenlein, Klein, Lobell, Lorenz, Weiss.
Ratification of KPMG LLP as independent auditor for FY2025 approved: 20,400,173 for, 314,490 against.
Advisory vote on executive compensation passed: 9,388,005 for, 312,265 against, 10,917,039 broker non-votes.
Board sets say-on-pay frequency every three years until 2031; vote: 2,051,405 for one year, 7,421,176 for three years.
Charter amendment for officer exculpation approved: 7,964,484 for, 1,723,623 against, 10,917,039 broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.